Home NDC 67296-1089-2 Acyclovir
Product NDC 67296-1089
Requested package NDC 67296-1089-2
11-digit product format 672961089
Labeler code 67296
Product ID 67296-1089_d60fd320-eb37-4489-e053-2995a90a8432
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Acyclovir
Dosage form TABLET
Route ORAL
Labeler RedPharm Drug, Inc.
Application ANDA203834
Marketing category ANDA
Marketing start 2013-11-29
Marketing end 0000-00-00
Substance ACYCLOVIR
Active strength 400 mg/1
Pharmacologic classes DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]
NDC exclude flag No
Listing certified through 2023-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 16 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Code, Status table Captured / source date Code Status Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 I Inactivated by FDA d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 I Inactivated by FDA f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 I Inactivated by FDA 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 I Inactivated by FDA a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 I Inactivated by FDA cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 I Inactivated by FDA cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 I Inactivated by FDA 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 I Inactivated by FDA ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 I Inactivated by FDA 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 I Inactivated by FDA ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 I Inactivated by FDA 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 I Inactivated by FDA 557ba5c1ecfa…9c80585c8c6e…2024-05-28 21:12 UTC · source 2024-05-28 I Inactivated by FDA 8af77b9d5b6f…d9bbb34c5368…2024-05-15 03:39 UTC · source 2024-05-14 I Inactivated by FDA 834df4deac94…adcc014656a3…2024-03-11 06:39 UTC · source 2024-03-08 I Inactivated by FDA 1332a3947898…d4bfe170f9cd…2019-12-08 06:16 UTC · source 2019-12-05 E Excluded after deficient or non-compliant submission was not corrected 110d247fa046…a55b01930146…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 44 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A203834-001 ACYCLOVIR ACYCLOVIR 400MG TABLET / ORAL AB 2013-10-29 A203834-002 ACYCLOVIR ACYCLOVIR 800MG TABLET / ORAL AB RS 2013-10-29
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 2 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 3 · 88 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-10-15 13:18:30 2026-09 A203834-001 ACYCLOVIR 400MG TABLET / ORAL AB 2013-10-29 c2088c7a36db…2026-10-15 13:18:30 2026-09 A203834-002 ACYCLOVIR 800MG TABLET / ORAL AB RS 2013-10-29 c2088c7a36db…2026-09-14 22:38:34 2026-08 A203834-001 ACYCLOVIR 400MG TABLET / ORAL AB 2013-10-29 84e616aacf4f…2026-09-14 22:38:34 2026-08 A203834-002 ACYCLOVIR 800MG TABLET / ORAL AB RS 2013-10-29 84e616aacf4f…2026-08-18 06:07:40 2026-07 A203834-001 ACYCLOVIR 400MG TABLET / ORAL AB 2013-10-29 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A203834-002 ACYCLOVIR 800MG TABLET / ORAL AB RS 2013-10-29 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A203834-001 ACYCLOVIR 400MG TABLET / ORAL AB 2013-10-29 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A203834-002 ACYCLOVIR 800MG TABLET / ORAL AB RS 2013-10-29 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A203834-001 ACYCLOVIR 400MG TABLET / ORAL AB 2013-10-29 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A203834-002 ACYCLOVIR 800MG TABLET / ORAL AB RS 2013-10-29 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A203834-001 ACYCLOVIR 400MG TABLET / ORAL AB 2013-10-29 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A203834-002 ACYCLOVIR 800MG TABLET / ORAL AB RS 2013-10-29 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A203834-001 ACYCLOVIR 400MG TABLET / ORAL AB 2013-10-29 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A203834-002 ACYCLOVIR 800MG TABLET / ORAL AB RS 2013-10-29 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A203834-001 ACYCLOVIR 400MG TABLET / ORAL AB 2013-10-29 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A203834-002 ACYCLOVIR 800MG TABLET / ORAL AB RS 2013-10-29 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A203834-001 ACYCLOVIR 400MG TABLET / ORAL AB 2013-10-29 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A203834-002 ACYCLOVIR 800MG TABLET / ORAL AB RS 2013-10-29 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A203834-001 ACYCLOVIR 400MG TABLET / ORAL AB 2013-10-29 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A203834-002 ACYCLOVIR 800MG TABLET / ORAL AB RS 2013-10-29 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A203834-001 ACYCLOVIR 400MG TABLET / ORAL AB 2013-10-29 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A203834-002 ACYCLOVIR 800MG TABLET / ORAL AB RS 2013-10-29 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A203834-001 ACYCLOVIR 400MG TABLET / ORAL AB 2013-10-29 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A203834-002 ACYCLOVIR 800MG TABLET / ORAL AB RS 2013-10-29 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A203834-001 ACYCLOVIR 400MG TABLET / ORAL AB 2013-10-29 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A203834-002 ACYCLOVIR 800MG TABLET / ORAL AB RS 2013-10-29 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A203834-001 ACYCLOVIR 400MG TABLET / ORAL AB 2013-10-29 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A203834-002 ACYCLOVIR 800MG TABLET / ORAL AB RS 2013-10-29 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A203834-001 ACYCLOVIR 400MG TABLET / ORAL AB 2013-10-29 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A203834-002 ACYCLOVIR 800MG TABLET / ORAL AB RS 2013-10-29 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A203834-001 ACYCLOVIR 400MG TABLET / ORAL AB 2013-10-29 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A203834-002 ACYCLOVIR 800MG TABLET / ORAL AB RS 2013-10-29 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A203834-001 ACYCLOVIR 400MG TABLET / ORAL AB 2013-10-29 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 A203834-002 ACYCLOVIR 800MG TABLET / ORAL AB RS 2013-10-29 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A203834-001 ACYCLOVIR 400MG TABLET / ORAL AB 2013-10-29 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A203834-002 ACYCLOVIR 800MG TABLET / ORAL AB RS 2013-10-29 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 A203834-001 ACYCLOVIR 400MG TABLET / ORAL AB 2013-10-29 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 A203834-002 ACYCLOVIR 800MG TABLET / ORAL AB RS 2013-10-29 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 A203834-001 ACYCLOVIR 400MG TABLET / ORAL AB 2013-10-29 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 A203834-002 ACYCLOVIR 800MG TABLET / ORAL AB RS 2013-10-29 4b0b4de00fa7…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 3 · 88 observed states.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed Product Concepts# FDA-Initiated Inactive NDC Indexing# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 67296-1089-2 Acyclovir 20 in 1 BOTTLE TABLET 20 3 67296-1089-5 Acyclovir 15 in 1 BOTTLE TABLET 15 3
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 67296-1089 ACYCLOVIR TABLET [REDPHARM DRUG, INC.] 3 Legacy NDC, 2 package rows 20220121_4e7965f2-09ba-6f9a-e054-00144ff8d46c.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 2 of 2 · 22 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 67296-1089-2 67296108902 20 TABLET in 1 BOTTLE (67296-1089-2) 20 tablet 2013-11-29 0000-00-00 No No Current